Models:
Joseph Gordon
joseph-gordon/
ClinicalTrialsElig
0
Downloads: 1
[c09aa8]: / clusters / 9knumclustersv2 / clust_209.txt

Download this file

113 lines (112 with data), 16.2 kB 

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (up to  days before treatment initiation)

Within  days of treatment initiation:\r\nHemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation

Hemoglobin >=  g/dL or >= . mmol/L (without transfusion or growth factor support/erythropoietin [EPO] dependency)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Within  (except as noted) days of planned treatment initiation: Hemoglobin >= . g/dL or >= . mmol/L without transfusion or erythropoietin dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L, performed within  days of treatment initiation, without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Within  days of treatment registration: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) within  days of treatment initiation

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of treatment initiation)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of study registration

Performed within  business days of treatment initiation with the exception of beta- HCG ( hours), if applicable: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment).

Performed within  days of treatment initiation: Hemoglobin ?  g/dL or ? . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), should be performed within  days of treatment initiation

Hemoglobin >=  g/dL without transfusion or erythropoietin (EPO) dependency

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment

Hemoglobin ?  g/dL or ? . mmol/L within  days of treatment initiation without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Performed within  days of treatment initiation: hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of treatment initiation)

Within  days prior to the start of study treatment: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment).

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

To be performed within  days of treatment initiation: hemoglobin ?  g/dL or ? . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment).

Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment).

Obtained =<  days prior to registration: Hemoglobin > . g/dL or >= . mmol/L without transfusion or (EPO) erythropoietin dependency (within  days of assessment)

Within  days prior to on-study date: Hemoglobin ?  g/dL (or ? . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL without transfusion or erythropoietin (EPO) dependency within  days

Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Within  days of treatment initiation: Hemoglobin ?  g/dL or ? . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin ?  g/dL or ? . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of treatment initiation)

Performed within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L\r\n* Patients cannot have received transfusion or erythropoietin (EPO) within  days of the hemoglobin (Hgb) lab test

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation

Obtained =<  days prior to registration: Hemoglobin >= . g/dL without transfusion or erythropoietin (EPO) dependency (=<  days prior to assessment)

Performed within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation

Performed within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of registration

Performed within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of registration)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (within - days of treatment initiation)

Hemoglobin >=  g/dL without transfusion or erythropoietin (EPO) dependency within  days performed within  days of treatment initiation performed within  days of treatment initiation

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), during screening and on cycle , day 

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) within  days of treatment initiation

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of treatment initiation)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin: >=  g/dL or . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Completed within  days of SBRT treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency\r\n(within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin ?  g/dL OR ?  g/dL if anemia due to iBCL, without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), should be performed within  days of treatment initiation

Hemoglobin >=  g/dL or >= . mmol/L with transfusion or erythropoietin (EPO) dependency

REGISTRATION TO TREATMENT (STEP ): Hemoglobin (Hgb) >= . g/dL OR >= . mmol/L without transfusion of erythropoietin (EPO) dependency, within  days prior to first dose of pembrolizumab

REGISTRATION TO TREATMENT (STEP ): Hgb >= . g/dL OR >= . mmol/L without transfusion of EPO dependency, within  days prior to first dose of pembrolizumab

Within  days of treatment initiation: hemoglobin >=  g/dl without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation

Within  days of treatment initiation: Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin (Hgb) >  g/dL (without transfusion or erythropoietin [EPO] dependency within  days of assessment)

Hemoglobin >= . g/dL (. mmol/L or  g/L) without transfusion or erythropoietin (EPO) dependency (within  days of assessment) obtained =<  days prior to registration

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of treatment initiation)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (within  days prior to day  of protocol therapy)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of treatment initiation)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), performed within  days of treatment initiation

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment), should be performed within  days of treatment initiation, unless otherwise indicated

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) within  days of treatment initiation

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment) (performed within  days of treatment initiation)

Hemoglobin (Hgb) >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment of Hgb), obtained within  days prior to C-AMT PET scan

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin dependency (=<  days prior to registration), obtained =<  days prior to registration

Hemoglobin >=  g/dL or >= . mmol/L without transfusion or erythropoietin (EPO) dependency (within  days of assessment)